Drawing for QSTAT

USPTO serial 90681821

QSTAT

Reviewed by CopyMark Law Group

Reg. 8439100Status 700Registered
Filing date
Status date
Registration date
Sep 15, 2026
Examiner
JOHNSON, BRITTANY S
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with QSTAT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael Greenbaum

Michael Greenbaum BLANK ROME LLPOne Logan Square, 130 N. 18th StreetPhiladelphia, PA 19103United States

Goods and services

ClassDescriptionStatusFirst use
009Electronic apparatus for scientific and laboratory research or use as educational apparatus and simulators, not for medical use, namely, wearable electronic sensors for scientific use to be worn by a human for gathering and recording of human biometric physiological parameters; electronic sensors and detectors, namely, accelerometers, temperature sensors, and gyroscopes; hardware interface boards, namely, interface cards for data processing equipment in the form of printed circuits; electric sensors; data communications hardware, namely, computer hardware for communicating audio, video and data between computers via a global computer network, wide-area computer networks, and peer-to-peer computer networks; electric sensors in the nature of wearable activity sensors; electric sensors, namely, wearable activity trackers; none of the foregoing for or in relation to cartridges of reagents for assessing hemostasis or measuring viscoelastic properties in a sampleACTIVEFeb 1, 2025
010Wearable electronic apparatus for medical use for monitoring vital signs, namely, electronic heart rate monitoring apparatus, electronic health monitors comprising electrodermal activity sensors, electronic blood pressure monitoring devices, electronic temperature monitors for medical use, electronic patient monitoring sensors; wearable electronic medical apparatus and instruments for monitoring vital signs, blood pressure, heart rate, and respiratory events; portable electronic medical devices in the nature of bracelets with sensors to monitor the physical movements of a patient wearing or carrying the device; wearable electronic sensors for medical use to be worn by a human to gather human biometric data and also including sensors, accelerometers, and gyroscopes sold as a unit; electronic analyzers for medical diagnostics, namely, wearable electronic activity sensors and monitors to detect and analyze epilepsy rates of patients during various activities; wearable electronic health monitors comprising activity sensors that monitor human health data; electronic monitoring instruments for medical use, namely, electronic temperature monitors for medical use, electronic heartbeat measuring apparatus, blood pressure measuring electronic devices; wearable electronic devices for monitoring blood pressure for medical use; electronic medical apparatus and instruments in the nature of wearable electronic bracelets for monitoring vital signs, blood pressure, heart rate, and respiratory events; wearable electric medical instruments for recording heart activity, changes in vital signs, blood pressure, heart rates, respiratory events; Medical electrodes for measuring biological parameters; none of the foregoing for use in hospitals or emergency rooms; none of the foregoing for or in relation to cartridges of reagents for assessing hemostasis or measuring viscoelastic properties in a sampleACTIVEFeb 1, 2025

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 15, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 15, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 25, 2026SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Aug 25, 2026CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
May 12, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
May 11, 2026IUAFUSE AMENDMENT FILED—
May 11, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Oct 30, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 30, 2025EX5GSOU EXTENSION 5 GRANTED—
Oct 29, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 28, 2025EXT5SOU EXTENSION 5 FILED—
May 8, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 8, 2025EX4GSOU EXTENSION 4 GRANTED—
May 7, 2025EXT4SOU EXTENSION 4 FILED—
May 7, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 3, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 3, 2024EX3GSOU EXTENSION 3 GRANTED—
Dec 3, 2024AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 8, 2024EXT3SOU EXTENSION 3 FILED—
Nov 8, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 15, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 14, 2024EX2GSOU EXTENSION 2 GRANTED—
Mar 14, 2024EXT2SOU EXTENSION 2 FILED—
Mar 14, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 19, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 17, 2023EX1GSOU EXTENSION 1 GRANTED—
May 17, 2023EXT1SOU EXTENSION 1 FILED—
May 17, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 9, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 14, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 14, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 22, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 3, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 2, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 2, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 2, 2023ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Aug 3, 2022GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 3, 2022GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 3, 2022CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 30, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 29, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 29, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 29, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 29, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 29, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 28, 2021DOCKASSIGNED TO EXAMINER—
Aug 4, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 3, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance